| | 
Part, Chapter, Paragraph
1 I, 2. 11 | Gesler, W., Preisser, J., Sherman, J., Spencer,
2 I, 2. 11 | Preisser, J., Sherman, J., Spencer, J., Perin, J. (
3 I, 2. 11 | Sherman, J., Spencer, J., Perin, J. (2005): The
4 I, 2. 11 | J., Spencer, J., Perin, J. (2005): The effects of
5 I, 2. 11 | indigenous populations. Int J Circumpolar Health. 2007
6 I, 2. 11 | 113(7), 823-839.~Rantanen J (1998): The changing world
7 I, 2. 11 | R, Tsolova S, Mortensen J (2005): The impact of health
8 I, 3. 4 | Haag.~ ~Bloom D E, Trussell J (1984): What Are the Determinants
9 I, 3. 4 | en Europe, in A. Blum e J. L. Rallu (eds) Démographie
10 II, 4. 3 | Health and Welfare.~ ~Riley, J. C. (1990): The risk of
11 II, 4. 3 | 16(3): 403-432.~ ~Robine, J.-M. and C. Jagger (2007):
12 II, 4. 3 | Ashgate: 317-328.~ ~Robine, J.-M. and C. Jagger (2007):
13 II, 4. 3 | Montpellier, Inserm~ ~Robine, J.-M., C. Jagger, et al. (
14 II, 4. 3 | 1-2): 119-133.~ ~Robine, J.-M., C. Jagger, et al. (
15 II, 4. 3 | Health 13(3): 6-14.~ ~Robine, J.-M., C. Jagger, et al.,
16 II, 4. 3 | 2003; 13:6-14.~ ~Robine, J.-M., C. Jagger, et al. (
17 II, 4. 3 | LVII(2): 89-101.~ ~Robine, J.-M., S. Le Roy, et al. (
18 II, 4. 3 | EHEMU: 9-48.~ ~Robine, J.-M. and J.-P. Michel (2004):
19 II, 4. 3 | 48.~ ~Robine, J.-M. and J.-P. Michel (2004): Looking
20 II, 4. 3 | Services: 34.~ ~Van Oyen, H., J. van der Heyden, et al. (
21 II, 5. 2. 4 | reduced CVD incidence (Wellman J, 2004).~Due to differences
22 II, 5. 2. 6 | epidemiological studies (Stamler J et al, 1986). The association
23 II, 5. 2. 6 | Framingham Study. Am Heart J 110: 1100-1107.~Kannel WB (
24 II, 5. 2. 6 | Zutphen Elderly Study). J Hypertens 14: 1159-1166.~
25 II, 5. 2. 6 | R, Sherliker P, Emberson J, Halsey J, Qizilbash N,
26 II, 5. 2. 6 | Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins
27 II, 5. 2. 6 | meta-regression analysis. J Am Coll Cardiol 46: 1855-
28 II, 5. 2. 6 | Cardiol 46: 1855-1862.~Stamler J, Wentworth D, Neaton JD (
29 II, 5. 2. 6 | cardiovascular disease. N Engl J Med 345: 1291-1297.~ ~
30 II, 5. 2. 7 | Bruxelles.~Daviglus ML, Stamler J, Pirzada A et al (2004):
31 II, 5. 2. 7 | Dyer AR, Wang R, Lubitz J et al (2005): Cardiovascular
32 II, 5. 2. 7 | the EUROCISS Project. Eur J Public Health 13: 55-60~
33 II, 5. 2. 7 | WHO MONICA Project. Int J Epidemiol 30 (1):S35-S40.~
34 II, 5. 2. 7 | Italian population samples. Am J Epid 163(10): 893-902.~Gra ).
35 II, 5. 2. 7 | executive summary. Eur Heart J 28: 2375-414~Greenland P,
36 II, 5. 2. 7 | Greenland P, Knoll MD, Stamler J,. Neaton JD, Dyer AR,. Garside
37 II, 5. 2. 7 | Treatment Panel III Guidelines. J Am Coll Cardiol 44: 720-
38 II, 5. 2. 7 | 1970 and 2000. Eur Heart J 27: 107-113.~Kuulasmaa K,
39 II, 5. 2. 7 | Ferrario M, Tuomilehto J (2000): Estimation of contribution
40 II, 5. 2. 7 | Chiodini P, Sega R, and Stamler J (2006): Favorable cardiovascular
41 II, 5. 2. 7 | the Progetto CUORE. Eur J Cardiovasc Prev Rehabil
42 II, 5. 2. 7 | R, Giampaoli S, Stamler J (2008): Preventive potential
43 II, 5. 2. 7 | study [htt rg/doi:10.1016/j.ypmed.2008.01.023] (accessed
44 II, 5. 2. 7 | Peto V, Rayner M, Leal J, Luengo-Fernandez R and
45 II, 5. 2. 7 | Vartiainen E, Tuomilehto J, Salomaa V, Nissinn A (1998):
46 II, 5. 2. 7 | Collaborative Research Group. N Engl J Med 344: 3-10.~Sans S, Kesteloot
47 II, 5. 2. 7 | statistics in Europe. Eur Heart J 18: 1231–48.~Sarti C, Stegmayr
48 II, 5. 2. 7 | H, MAhonen M, Tuomilehto J, Asplund K, for the WHO
49 II, 5. 2. 7 | disease: rates and trends. Int J Epidemiol 18 (suppl):S20–
50 II, 5. 2. 7 | countries from 1950 to 1978. Int J Epidemiol14: 510-20.~Tolonen
51 II, 5. 2. 7 | K, Vanuzzo D, Tuomilehto J for the WHO MONICA Project (
52 II, 5. 2. 7 | and Wales, 1981-2000. Am J Public Health 95 (1): 103-
53 II, 5. 2. 7 | Budaj A, Pais P, Varigo J, Lisheng A (2004): Effect
54 II, 5. 3. 9 | G, Verdecchia A, Estève J, Sant M, Storm H, Allemani
55 II, 5. 3. 9 | 9th June 2008).~ ~Ferlay J, Autier P, Boniol M, Heanue
56 II, 5. 3. 9 | nine prospective studies. J Natl Cancer Inst 94:606-
57 II, 5. 3. 9 | cancer health indicators. Eur J Public Health 13(3 Suppl):
58 II, 5. 3. 9 | Parkin DM, Bray F, Ferlay J, Pisani P (2005): Global
59 II, 5. 3. 9 | statistics, 2002. CA Cancer J Clin 55(2):74-108.~ ~Sant
60 II, 5. 3. 9 | Lasota M, Carli P, Faivre J, Grosclaude P, Hédelin G,
61 II, 5. 3. 9 | screening in Japan. N Engl J Med 350: 2010-1~ ~Verdecchia
62 II, 5. 4. 1 | history of diabetes is 'U' or 'J' shaped with relatively
63 II, 5. 4. 8 | 29, OECD 2006~Azzopardi J, Fenech FF, Junoussov Z,
64 II, 5. 4. 8 | Gudbjörnsdottir S, Cederholm J, Nilsson PM, Eliasson B;
65 II, 5. 4. 8 | myocardial infarction? Int J Clin Pract 61(4):680-3~Jönsson
66 II, 5. 4. 8 | Nystrom L, Wall S, Ostman J., Excess costs of medical
67 II, 5. 5.Int(11)| Austbury J. (2002): Mental Health:
68 II, 5. 5. 1 | 1.6. References~ ~Alonso J, Angermeyer MC, Bernert
69 II, 5. 5. 1 | suppl 420): 21-27.~ ~Alonso J, Angermeyer M, Bernert S, Bru t (
70 II, 5. 5. 1 | suppl 420):47-54.~ ~Alonso J, Lépine JP (2007). Overview
71 II, 5. 5. 1 | Mentl Disorders (ESEMeD). J Clin Psychiatry 68(suppl
72 II, 5. 5. 1 | TA, Collings SC, Atkinson J (2003). Unemployment and
73 II, 5. 5. 1 | for a causal association? J Epidemiol Community Health
74 II, 5. 5. 1 | Kovess V, Kessler RC, Alonso J and the ESEMED/MHEDEA Investigators (
75 II, 5. 5. 1 | National Comorbidity Survey. Br J Psychiatry 168(Suppl. 30):
76 II, 5. 5. 1 | Kovess-Masféty V, Alonso J, Brugha TS, Angermeyer MC,
77 II, 5. 5. 1 | from 3 European studies. J Clin Psychiatry 68(Suppl
78 II, 5. 5. 1 | review of the evidence. Am J Psychiatry 159(6):909-16.~ ~
79 II, 5. 5. 1 | Psychiatry 159(6):909-16.~ ~Ormel J, Petukhova M, Chaterji S, Agu C (
80 II, 5. 5. 1 | Mental Health Surveys. Br J Psychiatry 192(5):368-75.~ ~O A (
81 II, 5. 5. 1 | Systematic review. Bri J Psychiatry 181:193-9.~ ~T G (
82 II, 5. 5. 1 | of depression in Europe. J Mental Health Policy Econ
83 II, 5. 5. 1 | a systematic review. Am J Med 118(4):330-41.~ ~Värnik
84 II, 5. 5. 1 | Alliance Against Depression". J Epidemiol Community Health.
85 II, 5. 5. 2 | 31~ ~Godfrey M, Townsend J, Surr C, Boyle G and Brooker
86 II, 5. 5. 3 | Castillo M, Dallongeville J, Gilbert CC, Bergman P,
87 II, 5. 5. 3 | Jönsson B, Wittchen HU, Olesen J (2005): Cost of disorders
88 II, 5. 5. 3 | the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~
89 II, 5. 5. 3 | disorders in Europe. Eur J Neurol 12 Suppl 1:74-77.~
90 II, 5. 5. 3 | Andrews G, Sandersson K, Corry J, Issakidis C, Lapsley H (
91 II, 5. 5. 3 | treatment for schizophrenia. Br J Psychiatry 183:427-435.~
92 II, 5. 5. 3 | Decker P, Klosterkötter J, Maier W, Möller HJ, Gaebel
93 II, 5. 5. 3 | schizophrenia, A meta-analysis. Br J Psychiatry 171:502-8.~Buizza
94 II, 5. 5. 3 | population-based controlled study.~J Gen Intern Med 21(11):1133-
95 II, 5. 5. 3 | with schizophrenia. Can J Psychiatry 46:549-55.~Demyttenaere
96 II, 5. 5. 3 | Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine
97 II, 5. 5. 3 | Lara C, de Graaf R, Ormel J, Gureje O, Shen Y, Huang
98 II, 5. 5. 3 | Huang Y, Zhang M, Alonsro J, Haro JM, Vilagut G, Bromet
99 II, 5. 5. 3 | Association 291:2581–2590.~Engl J, Tschoner A, Laimer M, Rettenbacher
100 II, 5. 5. 3 | services for their patients? J Ment Health Policy Econ
101 II, 5. 5. 3 | epidemiological study. Nordic J. of Psychiatry 61(4):252-
102 II, 5. 5. 3 | Baumann AE, Klosterkötter J, Maier W, Decker P, Möller
103 II, 5. 5. 3 | survey and comparison Br J Psychiatry 187: 248-255.~
104 II, 5. 5. 3 | Bechdolf A, Klosterkötter J, Wagner M, Maier W, Bottlender
105 II, 5. 5. 3 | understanding the link? J Psychopharmacol 19: 56-65.~
106 II, 5. 5. 3 | D, Makikyro T, Suvisaari J, Peltonen L, Lonnqvist J (
107 II, 5. 5. 3 | J, Peltonen L, Lonnqvist J (1997): Schizophrenia in
108 II, 5. 5. 3 | JK, Galderisi S, Libiger J, Hummer M, Dollfus S, Lopez-Ibor
109 II, 5. 5. 3 | M, Dollfus S, Lopez-Ibor J, Hranov LG, Gaebel W, Peuskens
110 II, 5. 5. 3 | Hranov LG, Gaebel W, Peuskens J, Lindefors N, Richer-Rössler
111 II, 5. 5. 3 | 1085-1097.~Klosterkötter J (2007): Prevention in Psychiatry: “
112 II, 5. 5. 3 | 4:172-173.~Klosterkötter J, Ruhrmann S, Schultze-Lutter
113 II, 5. 5. 3 | review of recent literature. J Clin Psychiatry 63(10):892-
114 II, 5. 5. 3 | S, Burkard T, Henderson J, Maj M, Sartorius N (2007):
115 II, 5. 5. 3 | guidelines institute. Br J Psychiatry 188:193.~Lindström
116 II, 5. 5. 3 | 193.~Lindström E, Eberhard J, Neovius M, Levander S (
117 II, 5. 5. 3 | 33-40.~Lysaker PH, Tsai J, Yanos P, Roe D (2007):
118 II, 5. 5. 3 | Bengtsson-Tops A, Dybbro J, Nilsson LL, Sandlund M,
119 II, 5. 5. 3 | Kuipers E, Garety P, Geddes J, Orbach G, Morgan C (2002):
120 II, 5. 5. 3 | Pitschel-Walz G, Bäuml J (2007): Psychotherapie bei
121 II, 5. 5. 3 | Saxena S, Maj M, Maselko J, Phillips MR, Rahman A (
122 II, 5. 5. 3 | Saha S, Chant D, McGrath J (2005): A systematic review
123 II, 5. 5. 3 | Saha S, Chant D, McGrrath J (2007): A systematic review
124 II, 5. 5. 3 | depot antipsychotics. Br J Psychiatry 153:214-7.~Spollen
125 II, 5. 5. 3 | Häfner H, Klosterkötter J, Maier W, Möller HJ, Gaebel
126 II, 5. 5. 3 | in a rural town. Aust N Z J Psychiatry.39(6):514-21.~ ~
127 II, 5. 5. 3 | Knapp M, Romeo R, Beecham J (2007): The economic consequences
128 II, 5. 5. 3 | greater flexibility. Br Med J 331:60-61.~Beilmann A, Napa
129 II, 5. 5. 3 | 253-267.~Blom S, Heijbel J, Bergfors PG (1978): Incidence
130 II, 5. 5. 3 | prevalence, and prognosis. J Neurol Neurosurg Psychiatry
131 II, 5. 5. 3 | a systematic review. Eur J Neurol 12:245-253.~Fraser
132 II, 5. 5. 3 | disorders. A meta-analysis. Br J Psychiatry 170:205-228.~
133 II, 5. 5. 3 | 205-228.~Jacoby A, Gorry J, Gamble C, Baker GA (2004):
134 II, 5. 5. 3 | prospectively over 11-14 years. J Neurol Neurosurg Psychiatry
135 II, 5. 5. 3 | Epilepsia 42:1025-1030.~Loiseau J, Loiseau P, Guyot M, et
136 II, 5. 5. 3 | Epilepsia 31:391-396.~Loiseau J, Picot MC, Loiseau P (1999):
137 II, 5. 5. 3 | associated health usage. J Neurol Neurosurg Psychiatry
138 II, 5. 5. 3 | sudden death in epilepsy. J Neurol Neurosurg Psychiatry
139 II, 5. 5. 3 | L, Blomquist HK, Heijbel J (1993): A community-based
140 II, 5. 5. 3 | Sidenvall R, Forsgren L, Heijbel J (1996): Prevalence and characteristics
141 II, 5. 5. 3 | onset in childhood. New Engl J Med 338:1715-1722.~Smeets
142 II, 5. 5. 3 | Behav 10:354-362.~Taylor J, Chadwick D, Johnson T (
143 II, 5. 5. 3 | in drivers with epilepsy. J Neurol Neurosurg Psychiatry
144 II, 5. 5. 3 | Battaglia M, Kesselring J, Ketelaer P, Thompson A
145 II, 5. 5. 3 | Mures County, Romania. Rom J Neurol Psychiatry 32:115-
146 II, 5. 5. 3 | Bencsik K, Rajda C, Füvesi J, et al (2001): The prevalence
147 II, 5. 5. 3 | Neurol 46:206-209.~Benedikz J, Magnus S, Guðmundsson J
148 II, 5. 5. 3 | J, Magnus S, Guðmundsson J et al (2002): The natural
149 II, 5. 5. 3 | 104:208-210.~Benito-Léon J, Martín E, Vela L et al (
150 II, 5. 5. 3 | among Danes with MS. Int MS J 13:66-71.~Buehler JW. Surveillance (
151 II, 5. 5. 3 | over a 25-year period. Eur J Neurol 8:463-469.~Confavreux
152 II, 5. 5. 3 | for multiple sclerosis. J Neurol Neurosurg Psychiatr
153 II, 5. 5. 3 | multiple sclerosis. N Engl J Med 343:1430–1438.~Confavreux
154 II, 5. 5. 3 | Scand 109:378-384.~De Sã J, Paulos A, Mendes H, et
155 II, 5. 5. 3 | District of Santarem, Portugal. J Neurol 253:914-918.~Dean
156 II, 5. 5. 3 | Malta in 1999: an update. J Neurol Neurosurg Psychiatry
157 II, 5. 5. 3 | trends, and prospects. Eur J Neurol 11:511–520~EUROPA.
158 II, 5. 5. 3 | gradients really exist? J Neurol 246:1033–1040.~Ford
159 II, 5. 5. 3 | Leeds Health Authority. J Neurol Neurosurg Psychiatry
160 II, 5. 5. 3 | multiple sclerosis in Leeds. J Neurol 249:260-265.~Fox-Rushby
161 II, 5. 5. 3 | indigeneous population. J Neurol 247;129-133.~Haffenden
162 II, 5. 5. 3 | in Northern Ireland, UK. J Neurol Neurosurg Psychiatry
163 II, 5. 5. 3 | effect of genetic diversity. J Neurol Neurosurg Psychiatry
164 II, 5. 5. 3 | Multiple sclerosis in Cyprus. J Neurol Sci 103:29-36.~Milanov
165 II, 5. 5. 3 | 307~Miller D, Noseworthy J, Compston A (2006): Care
166 II, 5. 5. 3 | province of Teruel, Spain. J Neurol 244:182-185.~Mor
167 II, 5. 5. 3 | Multiple sclerosis. N Engl J Med 343;938-952.~Peterlin
168 II, 5. 5. 3 | Peterlin B, Ristic S, Sepcic J, et al (2006): Region with
169 II, 5. 5. 3 | in Croatia and Slovenia. J Neurol Sci 247:169-172.~
170 II, 5. 5. 3 | sclerosis in Europe. Eur J Neurol 13: 700–722.~Pugliatti
171 II, 5. 5. 3 | 392.~Robertson NP, Deans J, Fraser M, Compston DAS (
172 II, 5. 5. 3 | districts of East Anglia. J Neurol Neurosurg Psychiatry
173 II, 5. 5. 3 | genetic predisposition. J Neurol Neurosurg Psychiatry
174 II, 5. 5. 3 | a critical overview. Can J Neurol Sci 20:17-29.~Sarasoja
175 II, 5. 5. 3 | 29.~Sarasoja T, Wikström J, Paltamaa J, et al (2004):
176 II, 5. 5. 3 | T, Wikström J, Paltamaa J, et al (2004): Occurrence
177 II, 5. 5. 3 | ML, Tienari PJ, Wikström J, Palo, J, Hakama M (2000):
178 II, 5. 5. 3 | Tienari PJ, Wikström J, Palo, J, Hakama M (2000): Regional
179 II, 5. 5. 3 | ML, Tienari PJ, Wikström J, Palo, J, Hakama M (2001):
180 II, 5. 5. 3 | Tienari PJ, Wikström J, Palo, J, Hakama M (2001): Increasing
181 II, 5. 5. 3 | Tienari PJ, Hakama M, Wikström J (2003): Multiple sclerosis
182 II, 5. 5. 3 | progressive disease courses. J Neurol Neurosurg Psychiatry
183 II, 5. 5. 3 | County in northern Sweden. J Neurol Neurosurg Psychiatry
184 II, 5. 5. 3 | County in northern Sweden. J Neurol Neurosurg Psychiatry
185 II, 5. 5. 3 | Valladolid, northern Spain. J Neurol 246:170-174.~Totaro
186 II, 5. 5. 3 | district, central Italy. J Neurol Neurosurg Psychiat
187 II, 5. 5. 3 | 352.~Trapp BD, Peterson J, Ransohoff RM, et al (1998):
188 II, 5. 5. 3 | multiple sclerosis. N Engl J Med 338:278-285.~Trisolini
189 II, 5. 5. 3 | 285.~Trisolini M, Wiener J, Miller D (2002): Principles
190 II, 5. 5. 3 | sclerosis in French farmers. J Neurol Neurosurg Psychiatry
191 II, 5. 5. 3 | population-based, prospective study. J Am Geriatr Soc 48(8):938-
192 II, 5. 5. 3 | Jonsson B, Wittchen HU, Olesen J (2005): Cost of disorders
193 II, 5. 5. 3 | the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~
194 II, 5. 5. 3 | 1358-1363.~Benito-Leon J, Bermejo-Pareja F, Rodriguez
195 II, 5. 5. 3 | Bermejo-Pareja F, Rodriguez J, Molina JA, Gabriel R, Morales
196 II, 5. 5. 3 | Parkinson’s disease. Br J Clin Pract 49(6):288-293.~
197 II, 5. 5. 3 | 293.~Claveria LE, Duarte J, Sevillano MD, Perez-Sempere
198 II, 5. 5. 3 | Rodriguez F, de Pedro-Cuesta J (2002): Prevalence of Parkinson’
199 II, 5. 5. 3 | in Parkinson's disease. J Neurol Sci. 262:37-44.~Errea
200 II, 5. 5. 3 | Aibar C, de Pedro-Cuesta J (1999): Prevalence of Parkinson’
201 II, 5. 5. 3 | Beech C, Bowman C, Holmes J, Kingdom WK, MacMahon DG,
202 II, 5. 5. 3 | for Parkinson’s disease. J Neurol Sci 217(2):169-174.~
203 II, 5. 5. 3 | Parkinson’s disease. Eur J Neurol 13(11):1170-1185.~
204 II, 5. 5. 3 | s disease in Europe. Eur J Neurol 12 Suppl 1:68-73.~
205 II, 5. 5. 3 | a Scottish city. Br Med J 292(6519):534-536.~Nath
206 II, 5. 5. 3 | Steele-Richardson-Olszewski syndrome). J Neurol Neurosurg Psych 76(
207 II, 5. 5. 3 | 568.~Riedel O, Klotsche J, Spottke A, Deuschl G, Forstl
208 II, 5. 5. 3 | of Parkinson’s disease. J Chronic Dis 26(4):243-254.~
209 II, 5. 5. 3 | Koehne-Volland R, Rieke J, Simonow A, Brandstaedter
210 II, 5. 5. 3 | multiple system atrophy. J Neural Transm 112(12):1605-
211 II, 5. 5. 3 | family, and the individual. J Am Geriatr Soc 45(7):844-
212 II, 5. 6. 6 | Epidemiological aspects of back pain. J Soc Occup Med 36:90-94~Andersson
213 II, 5. 6. 6 | pain localization. Clin J Pain 9:174-182~Arnett FC,
214 II, 5. 6. 6 | 1990 Ontario Health Survey. J Rheumatol 21:505-514~Badley
215 II, 5. 6. 6 | Swedish population study. J Rheumatol 28:1369-1377~Birnbaum
216 II, 5. 6. 6 | Arthritis to an Employer. J Occup Environ Med 42(6):
217 II, 5. 6. 6 | absence in Norway. Scand J Soc Med 26:34-43~Brooks
218 II, 5. 6. 6 | Nielsen H, Silman A, Smolen J, Yazici H (2007): EULAR
219 II, 5. 6. 6 | impact on quality of life. Am J Med 103:12S-17S~Cooper C,
220 II, 5. 6. 6 | osteoporotic fractures. Am.J Epidemiol 137:1001-1005~
221 II, 5. 6. 6 | Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995):
222 II, 5. 6. 6 | Fractures Research Group. N Engl J Med 332:767-773~Davis MA,
223 II, 5. 6. 6 | distribution and osteoarthritis. Am J Epidemiol 132:701-707~Department
224 II, 5. 6. 6 | osteoarthritis of the knee. J Rheumatol 19:378-384~EULAR
225 II, 5. 6. 6 | osteoporosis study (EPOS). J Bone Miner Res 17:716-724~
226 II, 5. 6. 6 | pain and sciatica. N Engl J Med 318:291-300~Hagen KB,
227 II, 5. 6. 6 | arthritis: a population survey. J Rheumatol 24:1703-1709~Hakala
228 II, 5. 6. 6 | retention of functional ability. J Rheumatol 21:1432-1437~Hochberg
229 II, 5. 6. 6 | Schulenburg JM, Zeidler H, Ruof J (2005): Direct Costs Related
230 II, 5. 6. 6 | Technology Assessment. Int J Technol Assess Health Care
231 II, 5. 6. 6 | Juni P, Dieppe P, Donovan J, Peters T, Eachus J, Pearson
232 II, 5. 6. 6 | Donovan J, Peters T, Eachus J, Pearson N, Greenwood R,
233 II, 5. 6. 6 | gatekeeper-model managed care plan. Am J Manag Care 6:669-678~Linos
234 II, 5. 6. 6 | prevalence, and mortality. Am J Epidemiol 111:87-98~Lock
235 II, 5. 6. 6 | Washington DC~Magaziner J, Simonsick EM, Kashner TM,
236 II, 5. 6. 6 | fracture: a prospective study. J Gerontol 45:M101-M107~Meerding
237 II, 5. 6. 6 | the general population. J Bone Miner Res 18:1139-1141~
238 II, 5. 6. 6 | in a local community. Eur J Gen Pract 1:25-28~Naz SM
239 II, 5. 6. 6 | Shen W, Cooper C, Kanis J (2000): Health-related quality
240 II, 5. 6. 6 | prevalent vertebral fractures. J Bone Miner Res 15:1384-1392~
241 II, 5. 6. 6 | the Dutch population. Am J Public Health 87:1680-1682~
242 II, 5. 6. 6 | musculoskeletal diseases. J Rheumatol 19:1020-1030~Sernbo
243 II, 5. 6. 6 | poorer quality of life? J Clin Epidemiol 53:895-907~
244 II, 5. 6. 6 | Stansfeld S, Feeney A, Head J, Canner R, North F, Marmot
245 II, 5. 6. 6 | 57:649-655~Van den Velden J, De Bakker DH, Claessens
246 II, 5. 7. 7 | 1):e382-e387.~Atthobari J, Asselbergs FW, Boersma
247 II, 5. 7. 7 | the AusDiab kidney study. J Am Soc Nephrol 2003;14(7
248 II, 5. 7. 7 | Suppl 2):S131-S138.~Chen J, Wildman RP, Gu D, Kusek
249 II, 5. 7. 7 | Aug;70(4):800-6.~Coresh J, Byrd-Holt D, Astor BC,
250 II, 5. 7. 7 | U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005 Jan;
251 II, 5. 7. 7 | Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O (
252 II, 5. 7. 7 | for chronic renal failure. J Am Soc Nephrol 2006 Jun;
253 II, 5. 7. 7 | 11(4):438-42.~Fadrowski J, Cole SR, Hwang W, Fiorenza
254 II, 5. 7. 7 | Cole SR, Hwang W, Fiorenza J, Weiss RA, Gerson A, et
255 II, 5. 7. 7 | hospitalization. N Engl J Med 2004 Sep 23;351(13):
256 II, 5. 7. 7 | 2801-8.~Hallan SI, Coresh J, Astor BC, Asberg A, Powe
257 II, 5. 7. 7 | prevalence and ESRD risk. J Am Soc Nephrol 2006; 17:
258 II, 5. 7. 7 | Grootendorst DC, Aasberg A, Holmen J, et al (2006b): Screening
259 II, 5. 7. 7 | among nondiabetic adults. J Am Soc Nephrol 2005 Jul;
260 II, 5. 7. 7 | 2001;16 Suppl 7:57-60~Lin J, Knight EL, Hogan ML, Singh
261 II, 5. 7. 7 | without kidney disease. J Am Soc Nephrol 2003 Oct;
262 II, 5. 7. 7 | long-term implications. J Am Soc Nephrol 2002;13(Suppl
263 II, 5. 7. 7 | general population. Eur Heart J 2006 May;27(10):1245-50.~
264 II, 5. 7. 7 | chronic kidney disease. Am J Kidney Dis 2006;47(Suppl
265 II, 5. 7. 7 | classification and stratification. Am J Kidney Dis 2002;39(Supple
266 II, 5. 7. 7 | chronic kidney disease. Am J Kidney Dis 2003;41(suppl
267 II, 5. 7. 7 | chronic kidney disease. Am J Kidney Dis 2003;42(Suppl
268 II, 5. 7. 7 | chronic kidney disease. Am J Kidney Dis 2004;43(Suppl
269 II, 5. 7. 7 | an evolving reality. Int J Health Care Finance Econ
270 II, 5. 7. 7 | Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et
271 II, 5. 7. 7 | Survey (NHANES) 1999-2002. J Gen Intern Med 2007 Jul;
272 II, 5. 7. 7 | a large HMO population. J Am Soc Nephrol 2004 May;
273 II, 5. 7. 7 | risk: a systematic review. J Am Soc Nephrol 2006 Jul;
274 II, 5. 8. 7 | 1164/ rccm.167.5.787. Am.J.Resp.Crit.Care Med. 167(
275 II, 5. 8. 7 | 167(5): 787-797.~ ~Balmes J, Becklake M, Blanc P, Henneberger
276 II, 5. 8. 7 | Burden of Airway Disease. Am. J. Respir. Crit. Care Med.
277 II, 5. 8. 7 | inorganic dust~Eur Respir J 23: 402-406.~ ~Bilde L,
278 II, 5. 8. 7 | Rud Svenning A, Dollerup J, Baekke Borgeskov H, Lange
279 II, 5. 8. 7 | Respiratory Diseases.~Eur Respir J 2007; 29: 233-239.~ ~Boutin-Forzano
280 II, 5. 8. 7 | pan-European estimation. Int J Tuberc Lung Dis 2007; 11:
281 II, 5. 8. 7 | position paper. Eur Respir J 2004; 23: 932-946.~ ~Cerveri
282 II, 5. 8. 7 | young adults. Eur Respir J 2003; 22: 413-417.~ ~Chapman
283 II, 5. 8. 7 | pulmonary disease. Eur Respir J 2006; 27: 188-207.~ ~Dal
284 II, 5. 8. 7 | Cerveri I, Corsico A, Sunyer J, Neukirch F, Kunzli N, Leynaert
285 II, 5. 8. 7 | obstructive pulmonary disease. Am J Respir Crit Care Med 2003;
286 II, 5. 8. 7 | Furhman C, Jougla E, Nicolauu J, Eilstein D, Delmas M-C (
287 II, 5. 8. 7 | Goodridge D., Lawson J., Duggleby W.,Marciniuk
288 II, 5. 8. 7 | Goljan-Geremek A, Zielinski J (2003): Diagnosis of airflow
289 II, 5. 8. 7 | implications for management. J Nurs Manag. 2008 Mar; 16(
290 II, 5. 8. 7 | meta-analysis. Eur Respir J 2006; 28: 523-532.~ ~Hansell
291 II, 5. 8. 7 | coding analysis. Eur Respir J 2003; 22: 809-814.~ ~Jansson
292 II, 5. 8. 7 | general adult population. Int J Tuberc Lung Dis 2005; 9:
293 II, 5. 8. 7 | Longitudinal Aging Study Amsterdam. J Clin Epidemiol 2004; 57:
294 II, 5. 8. 7 | Scharling H, Fabricius P, Vestbo J (2006): Developing COPD:
295 II, 5. 8. 7 | Europe: FP7. Eur Respir J 2007; 29: 223-225.~ ~Mannino
296 II, 5. 8. 7 | disease (COPD). A review. Nord J Psychiatry 2004; 58: 65-
297 II, 5. 8. 7 | M, de la Roza C, Morera J, Montemayor T, Gobartt E,
298 II, 5. 8. 7 | what's the difference? Eur J Public Health 2006; 16:
299 II, 5. 8. 7 | Murtagh E, Heaney L, Gingles J, Shepherd R, Kee F, Patterson
300 II, 5. 8. 7 | F, Patterson C, MacMahon J (2005): Prevalence of obstructive
301 II, 5. 8. 7 | the NICECOPD study. Eur J Epidemiol 2005; 20: 443-
302 II, 5. 8. 7 | pulmonary disease. Intern Med J 2004;34(11):608-14~ ~ ~Schirnhofer
303 II, 5. 8. 7 | Visick G, Thakrar B, Sykes J, Pride NB (2000): Recent
304 II, 5. 8. 7 | aged 40 to 55 years. Br J Gen Pract 2004; 54: 201-
305 II, 5. 8. 7 | 2004; 54: 201-206.~ ~Sunyer J, Zock JP, Kromhout H, Garcia-Esteban
306 II, 5. 8. 7 | Exposures in Young Adults Am. J. Respir. Crit. Care Med.
307 II, 5. 8. 7 | history of COPD. Eur Respir J 2007; 30: 993–1013~ ~Vrbica
308 II, 5. 8. 7 | smoking cigarettes. Eur J Epidemiol 2004; 19: 147-
309 II, 5. 8. 7 | 19: 147-53.~ ~Zielinski J, Bednarek M, Gorecka D,
310 II, 5. 8. 7 | COPD awareness. Eur Respir J 2006; 27: 833-852.~ ~Zock
311 II, 5. 8. 7 | 852.~ ~Zock J-P, Sunyer J, Kogevinas M, Kromhout H,
312 II, 5. 8. 7 | International Study Am. J. Respir. Crit. Care Med.
313 II, 5. 9. FB | FB.9. References~ ~Plumb J, Brawer R, Brisbon N (2007):
314 II, 5. 9. 7 | costs of asthma. Eur Respir J. 2006 Apr;9(4):636-42~ ~Bj P (
315 II, 5. 9. 7 | Pt 1):585-92~ ~Bousquet J (2003): Allergic Rhinitis
316 II, 5. 9. 7 | Health Survey. Eur Respir J, 1994, 7, 954-960~ ~Compalati
317 II, 5. 9. 7 | Allergy Clin Immunol Int – J World Allergy Org; 19:82-
318 II, 5. 9. 7 | inhalant allergens in adults. J Allergy Clin Immunol. 2003
319 II, 5. 9. 7 | history of asthma in Italy. J Allergy Clin Immunol. 2002
320 II, 5. 9. 7 | Steering Committee. Eur Respir J 2002; 20:1071-1079~ ~Fasce
321 II, 5. 9. 7 | Available at: www ~ ~Heinrich J Gehring U, , Jacob B, Richter
322 II, 5. 9. 7 | Luczynska C, Chinn S, Potts J, Stunyer J, Janson C, Svanec
323 II, 5. 9. 7 | Chinn S, Potts J, Stunyer J, Janson C, Svanec C, Kunzly
324 II, 5. 9. 7 | historical perspective. J Laryngol Otol. Dec;117(12):
325 II, 5. 9. 7 | PhyCor experience. Jt Comm J Qual Improv. 1999 Feb;25(
326 II, 5. 9. 7 | 60-5~ ~Schipper H, Clinch J, Olweny CLM (1990): Quality
327 II, 5. 9. 7 | detection, and diagnosis. J Allergy Clin Immunol. 2001
328 II, 5. 9. 7 | RHINE study. Eur Respir J 2004; 24: 942-946~ ~To E,
329 II, 5. 9. 7 | Results of an Italian study. J Allergy Clin Immunol. 2003
330 II, 5. 9. 7 | environmental antigens. J Allergy Clin Immunol. 2006
331 II, 5. 10. 7 | Hoffmann-Sommergruber K, Lidholm J, Mustakov T, Oude Elberink
332 II, 5. 10. 7 | Kosunen TU, Hook-Nikanne J, Salomaa A, Sarna S, Aromaa
333 II, 5. 10. 7 | T, Goldhahn K, Dahlstrom J (2007): The prevalence of
334 II, 5. 10. 7 | allergy: A meta-analysis. J Allergy Clin Immunol 120,
335 II, 5. 10. 7 | in coeliac disease. Eur J Gastroenterol Hepatol 13:
336 II, 5. 10. 7 | A, Crevel R, Fitzpatrick J, Mills C, Privalle L, Vieths
337 II, 5. 10. 7 | young adults. Eur Respir J 1998; 11(1):151-155.~ ~Woods
338 II, 5. 10. 7 | Survey (ECRHS) 1991-1994. Eur J Clin Nutr 2001; 55(4):298-
339 II, 5. 10. 7 | Woods RK, Stoney RM, Raven J, Walters EH, Abramson M,
340 II, 5. 10. 7 | allergy in the community. Eur J Clin Nutr; 56(1):31-36.~ ~
341 II, 5. 11. 3 | skin diseases in Europe Eur J Dermatol 2006;16:212-218~ ~ ~
342 II, 5. 11. 7 | clinicopathological characteristics. J Dermatol 2003;30:123–131.~ ~
343 II, 5. 11. 7 | for population surveys. Br J Dermatol 2003;149:794-800.~ ~
344 II, 5. 11. 7 | decreases in Scandinavia. Int J Cancer 2003;107:119–126.~ ~
345 II, 5. 11. 7 | epidemiology of skin cancer. Br J Dermatol 2002;146(S61):1-
346 II, 5. 11. 7 | 2002;146(S61):1-6.~ ~Ferlay J, Bray F, Pisani P, Parkin
347 II, 5. 11. 7 | from a European survey. J Eur Acad Dermatol Venereol
348 II, 5. 11. 7 | Literature review. Onychomycosis. J Eur Acad Dermatol Venereol.
349 II, 5. 11. 7 | hospital-based assessment. Br J Dermatol 1994;131(S44):34.~ ~
350 II, 5. 11. 7 | Statistics 1978: 1–72~ ~Kay J, Gawkrodger DJ, Mortimer
351 II, 5. 11. 7 | in a general population. J Am Acad Dermatol 1994;30:
352 II, 5. 11. 7 | an update, 1976–1998. Eur J Cancer Prev 2001;10:371–
353 II, 5. 11. 7 | Neame RL, Berth-Jones J, Kurinczuk JJ et al (1995):
354 II, 5. 11. 7 | possible ethnic variation. Br J Dermatol 1995;132:772-7.~ ~
355 II, 5. 11. 7 | use of medical care. Brit J Prev Soc Med 1976;30:107–
356 II, 5. 11. 7 | Disability in Dermatology. Br J Hosp Med 1991;46:33–6.~ ~
357 II, 5. 11. 7 | atopic eczema eds T Ruzicka, J Ring, B Pryzbilla). London:
358 II, 5. 11. 7 | EDEN hand-eczema survey. Br J Dermatol 2004;151(2):446-
359 II, 5. 11. 7 | international comparison. Br J Dermatol 2002;147:716-24.~ ~
360 II, 5. 11. 7 | onychomycosis in Britain. Br J Dermatol 1993;129:101-109.~ ~
361 II, 5. 11. 7 | of the advantaged? Br Med J 1994;308:1132-35.~ ~Williams
362 II, 5. 11. 7 | for atopic dermatitis. Br J Dermatol (1994b):131:383-
363 II, 5. 11. 7 | risk of atopic dermatitis. J Am Acad Dermatol 1995;32:
364 II, 5. 11. 7 | In: Stevens A, Raftery J, eds. Health Care Needs
365 II, 5. 11. 7 | skin diseases in Europe Eur J Dermatol 2006:16:212-218.~ ~ ~ ~
366 II, 5. 12. 7 | 1988 through 1994. N Engl J Med 341:556-562.~ ~Armstrong
367 II, 5. 12. 7 | cirrhosis: an update to 2002. J Hepatol 46:827-839.~Chu
368 II, 5. 12. 7 | alcohol consumption. Int J Epidemiol 26:100-109.~ ~
369 II, 5. 12. 7 | 103:385-389.~de la Pena J, Brullet E, Sanchez-Hernandez
370 II, 5. 12. 7 | Martin -~ ~Ioannou G, Doust J, Rockey DC (2003): Terlipressin
371 II, 5. 12. 7 | benefits and risks. Int J Vitam Nutr Res 71:210-213.~ ~
372 II, 5. 12. 7 | Leon DA, McCambridge J (2006): Liver cirrhosis
373 II, 5. 12. 7 | a systematic review. Int J Cancer 111:1-8.~ ~Poynard
374 II, 5. 12. 7 | survival. Multi-centre group. J Hepatol 30:1130-1137.~ ~
375 II, 5. 12. 7 | S19-33.~ ~Sauer P, Hansmann J, Richter GM, Stremmel W,
376 II, 5. 15. 6 | orphan medicinal products. Br J Clin Pharmacol 2006, 62:
377 II, 5. 15. 6 | Kanavos P, Ubel P, Rovira J (2007): Assessing the economic
378 II, 5. 15. 6 | posed by orphan drugs. Int J Technol Assess Health Care.
379 II, 5. 15. 6 | treating rare diseases. N Engl J Med. 2006 Feb 2;354(5):445-
380 II, 5. 15. 6 | online version, OMIM. Am J Hum Genet, 80: 588-604,
381 II, 5. 15. 6 | rare diseases and orphan drugs. J Intern Med. 2006; 260(1):
382 II, 7. 7 | Board.~ ~MacKay M, Vincenten J, Brussoni M, Towner L (2006):
383 II, 7. 7 | MacKay M and Vincenten J (2007): Child Safety Summary
384 II, 8. 2. 1 | Cooper, S.-A. Morrison, J., Melville, C. Finlayson,
385 II, 8. 2. 1 | Melville, C. Finlayson, J., Allan, L., Martin, G.
386 II, 8. 2. 1 | Fujiura, G.T., Park, H. J. and Rutkowski-Kmitta, V. (
387 II, 8. 2. 1 | Accessed 17 October 2008~Mason, J., & Scior, K., (2004). Diagnostic
388 II, 8. 2. 1 | 42 (4), 264-272.~Rimmer,J.H. (1999). health promotion
389 II, 8. 2. 1 | E., Spreat, S., Tasse, M.J., Thompson, J.R., Verdugo,
390 II, 8. 2. 1 | Tasse, M.J., Thompson, J.R., Verdugo, M-A, Wehmeyer,
391 II, 8. 2. 1 | 124.~Schultz, S., Shenkin, J., & Horowitz, A. (2001).
392 II, 8. 2. 1 | Krahn G, Lennox N, Meaney J & Wehmeyer M (2005). Reducing
393 II, 8. 2. 1 | 4), 249-55.~Straetmans, J.M.J.A.A., H.M.J. van Schrojenstein
394 II, 8. 2. 1 | 249-55.~Straetmans, J.M.J.A.A., H.M.J. van Schrojenstein
395 II, 8. 2. 1 | Straetmans, J.M.J.A.A., H.M.J. van Schrojenstein Lantman-de
396 II, 8. 2. 1 | Valk, F.G. Schellevis, G.J. Dinant (2007). Health problems
397 II, 8. 2. 1 | European perspective. Eur J Public Health 13: 47-50;
398 II, 8. 2. 3 | Great Britain. International J Epidemiology. 1989;18:911-
399 II, 8. 2. 3 | in Sweden. International J Audiology. 2003;42:18-28~ ~
400 II, 9. 1. 1 | perinatal mortality. Am J Obstet Gynecol 2005;193(
401 II, 9. 1. 1 | outcomes in Europe. Eur J Obstet Gynecol Reprod Biol
402 II, 9. 1. 1 | descriptive study. Eur J Obstet Gynecol Reprod Biol
403 II, 9. 1. 1 | 86(4 Pt 2):700-5.~ ~Bai J, Wong FW, Bauman A, Mohsin
404 II, 9. 1. 1 | and pregnancy outcomes. Am J Obstet Gynecol 2002;186(
405 II, 9. 1. 1 | on birth certificates. Am J Public Health 1992;82(2):
406 II, 9. 1. 1 | Gissler M, Breart G, Zeitlin J (2006): Preterm birth and
407 II, 9. 1. 1 | Medical Experts Committee. Eur J Obstet Gynecol Reprod Biol
408 II, 9. 1. 1 | population in Europe. Eur J Obstet Gynecol Reprod Biol
409 II, 9. 1. 1 | C, Guillem P, Fauconnier J, Rambaud P, Jouk PS (2003):
410 II, 9. 1. 1 | Canterino JC, Ananth CV, Smulian J, Harrigan JT, Vintzileos
411 II, 9. 1. 1 | gestations: USA, 1995-2000. J Matern Fetal Neonatal Med
412 II, 9. 1. 1 | Five meta-analyses. Am J Prev Med 1999;16(3):208-
413 II, 9. 1. 1 | 208-15.~Cleary-Goldman J, Malone FD, Vidaver J, Ball
414 II, 9. 1. 1 | Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock
415 II, 9. 1. 1 | population-based study. Am J Obstet Gynecol 1993;168(
416 II, 9. 1. 1 | in The Netherlands. Eur J Obstet Gynecol Reprod Biol
417 II, 9. 1. 1 | retrospective study. Eur J Obstet Gynecol Reprod Biol
418 II, 9. 1. 1 | with singleton infants. Am J Obstet Gynecol 2004;191(
419 II, 9. 1. 1 | cesarean section. N Engl J Med 1989;321(4):233-9.~ ~
420 II, 9. 1. 1 | vitro fertilization. N Engl J Med 2002;346(10):725-30.~ ~
421 II, 9. 1. 1 | 2002;346(10):725-30.~ ~Holt J, Vold IN, Odland JO, Forde
422 II, 9. 1. 1 | Lorenz JM, Cleary-Goldman J, D'Alton ME, et al (2003):
423 II, 9. 1. 1 | Kramer MS, Seguin L, Lydon J, Goulet L (2000b): Socio-economic
424 II, 9. 1. 1 | dans 8 pays differents. J Gynecol Obstet Biol Reprod (
425 II, 9. 1. 1 | 358-66.~ ~Langhoff-Roos J, Kesmodel U, Jacobsson B,
426 II, 9. 1. 1 | birth weight and infant mortality. J Reprod Med 2004;49(10):812-
427 II, 9. 1. 1 | 2004;49(10):812-6.~Maher J, Macfarlane A (2004): Inequalities
428 II, 9. 1. 1 | the risk of stillbirth. Br J Obstet Gynaecol 1994;101(
429 II, 9. 1. 1 | in the United States. Am J Obstet Gynecol 2006;195(
430 II, 9. 1. 1 | L, Levasseur M, Schenker J, et al (1993):~Patterns
431 II, 9. 1. 1 | e815-25.~ ~van Roosmalen J, Schuitemaker NW, Brand
432 II, 9. 1. 1 | Bennebroek Gravenhorst J (2002): Substandard care
433 II, 9. 1. 1 | EPICure Study Group. N Engl J Med 2000;343(6):378-84.~ ~
434 II, 9. 1. 1 | 343(6):378-84.~ ~Zeitlin J, Blondel B, Alexander S,
435 II, 9. 1. 1 | 114(9):1097-103.~ ~Zeitlin J, Wildman K, Breart G, Alexander
436 II, 9. 1. 1 | the PERISTAT project. Eur J Obstet Gynecol Reprod Biol
437 II, 9. 1. 2 | H, Erickson EJ, Halliday J, Irgens LM, Lowry RB, McDonnell
438 II, 9. 1. 2 | RB, McDonnell R, Metneki J, Poetzsch S, Ritvanen A,
439 II, 9. 1. 2 | population in Europe. Eur J Obstet Gynecol Repr Biol,
440 II, 9. 1. 2 | Christiansen M, Goujard J, Steinbicker V, Roesch C,
441 II, 9. 1. 2 | Cordier S, Bergeret A, Goujard J, Ha M-C, Ayme S, Bianchi
442 II, 9. 1. 2 | Danaché B, De Vigan C, Fevotte J, Kiel G, Mandereau L, for
443 II, 9. 1. 2 | Ha M-C, Aymé S, Goujard J (1992): "Maternal Occupational
444 II, 9. 1. 2 | fortification in Canada. New Engl J Med 2007;357: 135-42.~Dolk
445 II, 9. 1. 2 | 441-447.~Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle
446 II, 9. 2. 7 | Heuveline P., Timberlake J.M. (2000): Toward A Child-Centered
447 II, 9. 2. 7 | 279~ ~Lerner, R.M., Orlos, J.B., Knapp, J.R. (1976):
448 II, 9. 2. 7 | R.M., Orlos, J.B., Knapp, J.R. (1976): Physical attractiveness,
449 II, 9. 2. 7 | in Europe, 1955—1995. Eur J Cancer. 37:785-809.~ ~Masoli
450 II, 9. 3. 1 | References~ ~Arber S, McKinlay J, Adams A, et al, (2006):
451 II, 9. 3. 1 | Lodding P, Lilja H, Hugosson J (2007): Prostate Cancer
452 II, 9. 3. 1 | Urol 51: 659-664~ ~Austbury J: (2002): Mental Health ‘
453 II, 9. 3. 1 | Cambridge~ ~Aytac, I., McKinlay, J. & Krane, R. (1999) The
454 II, 9. 3. 1 | study of vulvar cancer. J Natl Cancer Inst, 1997.
455 II, 9. 3. 1 | 148(9): 680-W137.~ ~Shah, J., (2002) Erectile dysfunction
456 II, 9. 3. 2 | outcomes in Europe. Eur J Obstet Gynecol Reprod Biol
457 II, 9. 3. 2 | descriptive study. Eur J Obstet Gynecol Reprod Biol
458 II, 9. 3. 2 | perinatal mortality. Am J Obstet Gynecol 2005;193(
459 II, 9. 3. 2 | 1995;86(4 Pt 2):700-5.~Bai J, Wong FW, Bauman A, Mohsin
460 II, 9. 3. 2 | and pregnancy outcomes. Am J Obstet Gynecol 2002;186(
461 II, 9. 3. 2 | on birth certificates. Am J Public Health 1992;82(2):
462 II, 9. 3. 2 | Gissler M, Breart G, Zeitlin J (2006): Preterm birth and
463 II, 9. 3. 2 | Medical Experts Committee. Eur J Obstet Gynecol Reprod Biol
464 II, 9. 3. 2 | population in Europe. Eur J Obstet Gynecol Reprod Biol
465 II, 9. 3. 2 | C, Guillem P, Fauconnier J, Rambaud P, Jouk PS (2003):
466 II, 9. 3. 2 | Canterino JC, Ananth CV, Smulian J, Harrigan JT, Vintzileos
467 II, 9. 3. 2 | gestations: USA, 1995-2000. J Matern Fetal Neonatal Med
468 II, 9. 3. 2 | Five meta-analyses. Am J Prev Med 1999;16(3):208-
469 II, 9. 3. 2 | 208-15.~ ~Cleary-Goldman J, Malone FD, Vidaver J, Ball
470 II, 9. 3. 2 | Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock
471 II, 9. 3. 2 | population-based study. Am J Obstet Gynecol 1993;168(
472 II, 9. 3. 2 | in The Netherlands. Eur J Obstet Gynecol Reprod Biol
473 II, 9. 3. 2 | retrospective study. Eur J Obstet Gynecol Reprod Biol
474 II, 9. 3. 2 | with singleton infants. Am J Obstet Gynecol 2004;191(
475 II, 9. 3. 2 | cesarean section. N Engl J Med 1989;321(4):233-9.~ ~
476 II, 9. 3. 2 | vitro fertilization. N Engl J Med 2002;346(10):725-30.~ ~
477 II, 9. 3. 2 | 2002;346(10):725-30.~ ~Holt J, Vold IN, Odland JO, Forde
478 II, 9. 3. 2 | Lorenz JM, Cleary-Goldman J, D'Alton ME, et al (2003):
479 II, 9. 3. 2 | Kramer MS, Seguin L, Lydon J, Goulet L (2000): Socio-economic
480 II, 9. 3. 2 | dans 8 pays differents.~J Gynecol Obstet Biol Reprod (
481 II, 9. 3. 2 | 358-66.~ ~Langhoff-Roos J, Kesmodel U, Jacobsson B,
482 II, 9. 3. 2 | birth weight and infant mortality. J Reprod Med 2004;49(10):812-
483 II, 9. 3. 2 | 2004;49(10):812-6.~ ~Maher J, Macfarlane A (2004): Inequalities
484 II, 9. 3. 2 | the risk of stillbirth. Br J Obstet Gynaecol 1994;101(
485 II, 9. 3. 2 | in the United States. Am J Obstet Gynecol 2006;195(
486 II, 9. 3. 2 | Schuitemaker N, van Roosmalen J, Dekker G, van Dongen P,
487 II, 9. 3. 2 | Bennebroek Gravenhorst J (1998): Confidential enquiry
488 II, 9. 3. 2 | Netherlands 1983-1992. Eur J Obstet Gynecol Reprod Biol
489 II, 9. 3. 2 | L, Levasseur M, Schenker J, et al (1993):~ ~Patterns
490 II, 9. 3. 2 | Hannaford P, Cattaneo A, Olsen J, Bloemenkamp KW, et al (
491 II, 9. 3. 2 | The REPROSTAT project. Eur J Obstet Gynecol Reprod Biol
492 II, 9. 3. 2 | e815-25.~ ~van Roosmalen J, Schuitemaker NW, Brand
493 II, 9. 3. 2 | Bennebroek Gravenhorst J (2002): Substandard care
494 II, 9. 3. 2 | EPICure Study Group. N Engl J Med 2000;343(6):378-84.~ ~
495 II, 9. 3. 2 | 343(6):378-84.~ ~Zeitlin J, Blondel B, Alexander S,
496 II, 9. 3. 2 | 114(9):1097-103.~ ~Zeitlin J, Wildman K, Breart G, Alexander
497 II, 9. 3. 2 | the PERISTAT project. Eur J Obstet Gynecol Reprod Biol
498 II, 9. 3. 3 | life-skill building (Shepherd J et al, 2000).~ ~
499 II, 9. 3. 3 | behaviour in Portugal. Int J STD&AIDS 15:56-60~Bajos
500 II, 9. 3. 3 | 56-60~Bajos N, Wadsworth J, Ducot B, Johnson AM, Le
|
|
| |
